Mapping the kinase domain of Janus Kinase 3

被引：44

作者：

Adams, C ^{[1
]}

Aldous, DJ ^{[1
]}

Amendola, S ^{[1
]}

Bamborough, P ^{[1
]}

Bright, C ^{[1
]}

Crowe, S ^{[1
]}

Eastwood, P ^{[1
]}

Fenton, G ^{[1
]}

Foster, M ^{[1
]}

Harrison, TKP ^{[1
]}

King, S ^{[1
]}

Lai, J ^{[1
]}

Lawrence, C ^{[1
]}

Letallec, JP ^{[1
]}

McCarthy, C ^{[1
]}

Moorcroft, N ^{[1
]}

Page, K ^{[1
]}

Rao, S ^{[1
]}

Redford, J ^{[1
]}

Sadiq, S ^{[1
]}

Smith, K ^{[1
]}

Souness, JE ^{[1
]}

Thurairatnam, S ^{[1
]}

Vine, M ^{[1
]}

Wyman, B ^{[1
]}

机构：

[1] Aventis Pharmaceut, Bridgewater, NJ 08807 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 18期

关键词：

D O I：

10.1016/S0960-894X(03)00657-7

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The utilization and impact of parallel synthesis on lead exploration around initial hit oxindole (1) are described. The emergent SAR, analogue design and functional impact will also be detailed. (C) 2003 Published by Elsevier Ltd.

引用

页码：3105 / 3110

页数：6

共 20 条

[1] Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice [J].

Cetkovic-Cvrlje, M ;

Dragt, AL ;

Vassilev, A ;

Liu, XP ;

Uckun, FM .

CLINICAL IMMUNOLOGY, 2003, 106 (03) :213-225

[2] A SHORT SYNTHESIS OF 4-AZAINDOL-2(3H)-ONES AND 6-AZAINDOL-2(3H)-ONES [J].

DAISLEY, RW ;

HANBALI, JR .

SYNTHETIC COMMUNICATIONS, 1981, 11 (09) :743-749

[3] Protein tyrosine kinase inhibitors: new treatment modalities? [J].

Fabbro, D ;

Parkinson, D ;

Matter, A .

CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (04) :374-381

[4] Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog [J].

Hubbard, SR .

EMBO JOURNAL, 1997, 16 (18) :5572-5581

[5] Active and inactive protein kinases: Structural basis for regulation [J].

Johnson, LN ;

Noble, MEM ;

Owen, DJ .

CELL, 1996, 85 (02) :149-158

[6] Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2 [J].

Lawrie, AM ;

Noble, MEM ;

Tunnah, P ;

Brown, NR ;

Johnson, LN ;

Endicott, JA .

NATURE STRUCTURAL BIOLOGY, 1997, 4 (10) :796-801

[7]

Leonard WJ, 1996, ANNU REV MED, V47, P229

[8] JAKS AND STATS: Biological implications [J].

Leonard, WJ ;

O'Shea, JJ .

ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :293-322

[9] Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors [J].

Mohammadi, M ;

McMahon, G ;

Sun, L ;

Tang, C ;

Hirth, P ;

Yeh, BK ;

Hubbard, SR ;

Schlessinger, J .

SCIENCE, 1997, 276 (5314) :955-960

[10] INTERLEUKIN-2 RECEPTOR GAMMA CHAIN MUTATION RESULTS IN X-LINKED SEVERE COMBINED IMMUNODEFICIENCY IN HUMANS [J].

NOGUCHI, M ;

YI, HF ;

ROSENBLATT, HM ;

FILIPOVICH, AH ;

ADELSTEIN, S ;

MODI, WS ;

MCBRIDE, OW ;

LEONARD, WJ .

CELL, 1993, 73 (01) :147-157

← 1 2 →